Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/34923
DC FieldValueLanguage
dc.contributor.authorCvetanovska, Marijaen_US
dc.contributor.authorGrozdanovski, Krstoen_US
dc.contributor.authorCana, Fadilen_US
dc.contributor.authorDemiri, Iliren_US
dc.contributor.authorSpasovska, Katerinaen_US
dc.contributor.authorCvetanovski, Vlatkoen_US
dc.contributor.authorStojanoska, Tatjanaen_US
dc.contributor.authorMilosavljevikj, Aneen_US
dc.date.accessioned2026-02-18T11:30:28Z-
dc.date.available2026-02-18T11:30:28Z-
dc.date.issued2024-10-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/34923-
dc.description.abstractAcute bacterial meningitis is an urgent condition characterized by significant morbidity and mortality. In the last decades, epidemiology of the most common etiologic agents as well as the age limit has changed significantly, with dominant involvement of the adult population and population at risk. Streptococcus pneumoniae remains the most common bacteria causing bacterial meningitis. The aim of this study is to observe the changes in the prevalence of etiologic agents and their dominance, the most commonly affected age groups, as well as comorbidities and complications in patients with acute bacterial meningitis treated at the University Clinic for Infectious Diseases in Skopje, R.N. Macedonia. In the last seven-year period, 194 patients with acute bacterial meningitis were treated. The etiologic agent in cerebrospinal fluid was confirmed in 94 (48.45%) patients, with the predominance of S. pneumoniae in 74 (78.72%). L. monocytogenes with 10 (10.63%) and N. meningitides with 6 (6.38%) were less represented. Male sex is dominant with 111 (57.21%) and older age groups as well. More than half of the patients, from the study, belonged to the at risk population with the highest percentage of them presenting with more than two comorbidities, as well as complications. In our study group, 41 (21.13%) of the patients died. Because of the substantial mortality and morbidity, it remains an urgent need to optimally deploy existing vaccines worldwide and develop new prevention strategies and treatment options.en_US
dc.language.isoenen_US
dc.publisherIMAB Peytchinski Publishing Ltd.en_US
dc.relation.ispartofJournal of IMAB. 2024 vol. 30, Supp 1en_US
dc.subjectacute bacterial meningitisen_US
dc.subjectS. Pneumoniaeen_US
dc.titleAcute bacterial meningitis – challenges and conclusionsen_US
dc.typeArticleen_US
dc.identifier.doihttps://www.journal-imab-bg.org/issues-2024/Supplement/2024v30Supplement1Medicine.pdf-
item.fulltextNo Fulltext-
item.grantfulltextnone-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.